AlphAIalphai — Financial news for AI agents
MarketBeatMAR 23 min read$STKS

ONE Group Hospitality (STKS) Expected to Announce Quarterly Earnings on Monday

ONE Group Hospitality (STKS) is anticipated to release its Q4 2025 earnings before market open on Monday, March 9th, with analysts projecting EPS of $0.26 and revenue around $210.28 million. The company has a low market capitalization of $62.82 million and exhibits financial strain with a negative P/E ratio, low liquidity, and high debt-to-equity. Despite this, institutional investors show mixed activity, and analysts hold a "Moderate Buy" consensus rating with a $4.50 target price.

Original reporting
MarketBeat · MarketBeat
Published Mar 2, 2026, 7:38 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 2, 2026, 8:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
ONE Group Hospitality (STKS) Expected to Announce Quarterly Earnings on Monday — source image
Source · MarketBeat
Decision brief

The 30-second read

$STKSNeutralLow
01

Why it matters

The upcoming earnings are unlikely to drastically alter the company's financial trajectory but may influence short-term trading activity.

02

Market read

Given the company's small market cap and financial strain, the earnings report is of limited relevance to broader market movements but may impact short-term trading in STKS.

03

What to watch

Potential strategic initiatives or upcoming catalysts not reflected in current financials could influence future performance.

Timing: short-term (within the next week)

Background

ONE Group Hospitality operates in the hospitality industry with a focus on upscale dining and nightlife venues. The company has faced financial challenges, including high debt levels and low liquidity.

Company-level read

Ticker impact

$STKSNeutralMedium confidence
Context

The upcoming earnings report is a significant event for the company, potentially impacting stock price.

Expected impact

Limited short-term price movement; potential for slight decline if earnings miss expectations.

Evidence & confidence

Financial indicators point to underlying weakness, but market sentiment is neutral, and earnings estimates are modest, suggesting limited immediate impact.

Market effects

Sector

The hospitality sector may experience minimal impact unless earnings significantly deviate from expectations.

Regional

Limited regional effects due to company-specific news.

Global

Low; the company is small-cap with limited global influence.

Counterpoint

What could challenge this read

Positive earnings surprise could lead to a short-term rally, especially if the company beats revenue estimates despite low profitability.

Key entities

  • Company
    ONE Group Hospitality

    A hospitality company operating upscale restaurants and nightlife venues.

Read at source← All news

Related articles

AUG 14
$STKSMed

ONE Group (STKS) Q2 2026 Earnings Call Transcript

ONE Group (STKS) held its Q2 2026 earnings call. The company reported $33 million operating cash flow in the first six months of 2026 versus $11 million a year earlier, and reduced net capex by about 38% year to date. Total revenue was about $200 million, down 3.2% y/y, while consolidated restaurant-level operating margin rose to 16.4%. Comparable sales grew 0.9% for the quarter.

yahoo.com7 min
AUG 5
$STKSMed

ONE Group Hospitality, Inc. (STKS): Results of Operations and Financial Condition

ONE Group Hospitality, Inc. (STKS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ ​ The ONE Group Reports Second Quarter 2026 Financial Results ​ Positive Comparable Sales, Positive Transactions Across All Business Segments ​ Capital Expenditures, Net of Tenant Improvement Allowances, Reduced 38% Year-Over-Year as Company Prioritizes Capital-Eff

SEC EDGAR 8-K6 min
SEP 8
$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

yahoo.com3 min
SEP 8
$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

theyeshivaworld.com2 min
SEP 8
$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.

yahoo.com2 min